{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:11:59Z","timestamp":1793664719711,"version":"4.5.1"},"reference-count":28,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100007819","name":"Allergan plc","doi-asserted-by":"crossref","award":["not available"],"award-info":[{"award-number":["not available"]}],"id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ocular Immunology and Inflammation"],"published-print":{"date-parts":[[2019,5,19]]},"DOI":"10.1080\/09273948.2018.1432764","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T15:32:11Z","timestamp":1521127931000},"page":"622-631","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Alcaftadine 0.25% versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study"],"prefix":"10.1080","volume":"27","author":[{"given":"Hiroshi","family":"Nakatani","sequence":"first","affiliation":[{"name":",","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gomes","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Bradford","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Safyan","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hollander","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0181-5512(06)73857-8"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000204"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2007.28.3013"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12009"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.06.050"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2007.00601.x"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.11-RAI-0335"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3282ef8674"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.10.042"},{"key":"e_1_3_3_11_1","first-page":"108","volume-title":"Allergic Diseases of the Eye","author":"Collum L","year":"2000","unstructured":"Collum L, Kilmartin DJ. Acute allergic conjunctivitis. In: Abelson MD, ed. Allergic Diseases of the Eye. Philadelphia: W.B. Saunders Co; 2000:108\u2013132."},{"key":"e_1_3_3_12_1","unstructured":"Lastacaft\u00ae (alcaftadine ophthalmic solution) 0.25% [prescribing information]. Irvine CA: Allergan plc; 2015. http:\/\/www.allergan.com\/assets\/pdf\/lastacaft_pi.pdf. Accessed November 10 2016."},{"key":"e_1_3_3_13_1","unstructured":"Pataday\u00ae (olopatadine hydrochloride ophthalmic solution) 0.2% [prescribing information]. Fort Worth TX: Alcon a Novartis Company; 2010. http:\/\/ecatalog.alcon.com\/pi\/Pataday_us_en.pdf. Accessed November 10 2016."},{"key":"e_1_3_3_14_1","unstructured":"Patanol\u00ae (olopatadine hydrochloride ophthalmic solution) 0.1% [prescribing information]. Fort Worth TX: Alcon a Novartis Company; 2007. http:\/\/ecatalog.alcon.com\/pi\/Patanol_us_en.pdf. Accessed November 10 2016."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e328357d3ba"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.all.0000183113.63311.11"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070030090035"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62814-1"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543409508835115"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1081\/BIP-120024206"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1783"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S15379"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S38671"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-014-0155-3"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S80503"},{"key":"e_1_3_3_26_1","first-page":"e6426","article-title":"Pharmacology of alcaftadine, a new antihistamine for ocular allergy","volume":"52","author":"Gallois-Bernos A","year":"2011","unstructured":"Gallois-Bernos A, Thurmond RL. Pharmacology of alcaftadine, a new antihistamine for ocular allergy. Invest Ophthalmol Vis Sci. 2011;52:e6426.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2011.47.12.1709243"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S15788"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2012.700756"}],"container-title":["Ocular Immunology and Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09273948.2018.1432764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:07:46Z","timestamp":1770941266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09273948.2018.1432764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5,19]]}},"alternative-id":["10.1080\/09273948.2018.1432764"],"URL":"https:\/\/doi.org\/10.1080\/09273948.2018.1432764","relation":{},"ISSN":["0927-3948","1744-5078"],"issn-type":[{"value":"0927-3948","type":"print"},{"value":"1744-5078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}